Cancer cell immunity in the crosshairs: Worth the expense?

Posted by on June 3, 2016 1:28 pm
Categories: health

Scientists have found unique genetic alterations that could indicate whether expensive immune checkpoint inhibitors would be effective for a particular patient. Their study reports that genetic alterations affecting a part of the PD-L1 gene increases the production of the protein, allowing cancer cells to escape detection by the immune system.

Leave a Reply

Your email address will not be published. Required fields are marked *